“Comparative Evaluation of Antibacterial Efficacy of Commercially Available Rhamnosus Derived Therapeutic Agent Against Cariogenic Microorganism” (2025) Asian Journal of Pharmaceutics (AJP), 19(3). doi:10.22377/ajp.v19i3.6750.